Ovarian Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have a cancer-related condition and are about to receive treatment that may harm their ability to have children in the future
- People whose body mass index (a measure of body weight relative to height) falls between 17.5 and 32
- People aged between 18 and 46 years old
Who may not be able to join:
- People who have had an allergic reaction to any of the medications used during the egg-stimulating process involved in this trial
- People who have tested positive for Hepatitis B, Hepatitis C, HIV, or syphilis
- People whose cancer care team has not given approval to proceed with the trial (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +393290636618
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Comparison of the number of oocytes retrieved per stimulation cycle in oncology patients undergoing fertility preservation before gonadotoxic therapy: ovarian tissue cryopreservation followed by oocyte cryopreservation vs. oocyte cryopreservation alone
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.